Literature DB >> 32858613

Pre-Planned Cranioplasty Using Computer-Assisted Designed Temporalis Muscle Augmentation in Patients With Decompressive Craniectomy Involving Resection of the Temporalis Muscle.

Gwangtae Park1, Jonghoon Kim, Chulhoon Chang, Youngjin Jung.   

Abstract

BACKGROUND: Decompressive craniectomy (DC) is the last-resort surgical procedure to reduce intracranial pressure and prevent secondary brain injury. Additional resection of the temporalis muscle and fascia can achieve a higher extracranial herniation volume compared to the standard DC technique at the expense of cosmetic problems for the patients. Various methods have been used to augment temporal fossa hollowing.
METHODS: To improve the cosmetic outcome, the authors report a patient who had a skull defect restored using a precisely shaped implant engineered via a computer using the opposite temporalis muscle as a mirror image. Polyether-ether-ketone cranioplasty was performed for the 52-year-old man with temporal hollowing after DC with resection of the temporalis muscle and fascia, due to a ruptured cerebral arteriovenous fistula.
RESULTS: The shape of the patient's surgical side was restored and not asymmetrical. The patient was very satisfied.
CONCLUSION: In the case of cranioplasty (CP) in patients with DC with resection of the temporalis muscle, CP with implants that include the opposite muscle may increase patient satisfaction without the risk of additional complications.
Copyright © 2020 by Mutaz B. Habal, MD.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32858613     DOI: 10.1097/SCS.0000000000006928

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  1 in total

1.  Cranioplasty and temporal hollowing correction with a three-dimensional printed bioresorbable mesh and double vertical suture anchor muscle sling: a case report.

Authors:  Jae Hyeok Choi; Tai Suk Roh; Won Jai Lee; Wooyeol Baek
Journal:  Arch Craniofac Surg       Date:  2022-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.